Intranet

Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria Grants for innovative haemostatic research on non-interventional observational studies focusing on patient outcomes, quality of life and social impact.
Característiques principals Areas of interest include, but are not limited to: Treatment options, outcome measures, and compliance Epidemiology of inhibitor development, including factors relevant to susceptibility Inhibitor management issues (e.g. with focus on tolerization/immunomodulation) Health economic outcomes Quality of care related areas including patients’ quality of life, unmet needs, and psychosocial issues associated with the disease Diagnosis and treatment of von Willebrand disease and platelet disorders Investigation of joint health; prophylaxis and improvement of long-term joint health outcomes In order to maintain a focus on the treatment of haemophilia and other rare bleeding disorders, Access to Insight clinical research grants will not support research focused on: Pathophysiology, diagnosis, and treatment of blood transmitted diseases Thrombotic disorders Products or technologies licensed or patented by competitors of Novo Nordiskisorders
Lloc de presentació IMIM and PSMAR staff who need more information should contact:: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: [email protected] Ext.: 1670 Marta López: [email protected] Ext.: 1576
Convocatòria (URL) https://access-to-insight.com/grant_clinical.php
Requisits Applicants should be health care professionals providing care for haemophilia and rare bleeding disorders patients, including nurses, physiotherapists, and psychologists.
Dotació €70,000
Durada 12 months

Arxius

Arxiu
Novo Nordisk - Your Access to Insight - Supporting global haemostasis research.pdf
A2I_Application-Process.pdf
application_form_clinical_research_grant.doc